{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "CTVA",
  "name": "Corteva, Inc.",
  "url": "https://frontierpicks.com/dossiers/CTVA/",
  "json_url": "https://frontierpicks.com/dossiers/CTVA.json",
  "status": "WATCHLIST",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Corteva, now a pure crop-protection company, is more likely to lag the S&P 500 after cutting its 2026 profit outlook on 11 November 2026 over a materially weaker Brazil. The early-2027 fourth-quarter report and the first 2027 outlook show whether Latin America stabilises.",
  "invalidation_trigger": "A daily close above $12.46, the 50-day average of adjusted closes as of 2026-11-11, which would show the shares recovering the whole post-report drop and leading. A fourth-quarter report showing Latin American organic sales growth would also prove the call wrong.",
  "catalyst_date": null,
  "portfolio": null,
  "pick": null,
  "themes": [],
  "tags": [],
  "sources": [],
  "notes": [
    "Corteva spun off its seed business as Vylor Inc. (NYSE: VYLR) on 2026-10-01, one share for one; quoted CTVA prices before that date reflect the combined company.",
    "Full-year 2026 guidance is stated on an adjusted pro forma basis for the stand-alone crop-protection business, not on reported GAAP figures."
  ],
  "source_links": [
    {
      "title": "Corteva, Inc. - Form 8-K - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0001755672/000175567226000031/a3q_2026xearningsxnewsxr.htm",
      "date": "2026-11-11"
    },
    {
      "title": "Corteva shares plunge 23% as earnings miss and weaker Brazil demand force guidance cut",
      "url": "https://www.proactiveinvestors.com/companies/news/1101691/corteva-shares-plunge-23-as-earnings-miss-and-weaker-brazil-demand-force-guidance-cut-1101691.html",
      "date": "2026-11-12"
    },
    {
      "title": "Corteva crop protection Q3 2026 slides reveal Brazil challenges",
      "url": "https://www.investing.com/news/company-news/corteva-crop-protection-q3-2026-slides-reveal-brazil-challenges-93CH-5022717",
      "date": "2026-11-12"
    },
    {
      "title": "Vylor Completes Corteva Spin-Off And Begins Trading On NYSE",
      "url": "https://pulse2.com/vylor-completes-corteva-spin-off-and-begins-trading-on-nyse/",
      "date": null
    }
  ],
  "evidence": [
    {
      "claim": "Q3 2026 net sales $1.591B, down 9%; price −7%, volume −2%; operating EBITDA $222M, down 17%; operating EPS $0.06, down 57%",
      "source": "Corteva Q3 2026 results release, 8-K",
      "as_of": "2026-11-11"
    },
    {
      "claim": "Latin America Q3 sales $570M, down 28% reported and 31% organic, on volume −24% and price −7%",
      "source": "Corteva Q3 2026 results release, 8-K",
      "as_of": "2026-11-11"
    },
    {
      "claim": "Full-year 2026 guidance cut to adjusted pro forma operating EBITDA of $1.100B-$1.125B and operating EPS of $0.76-$0.80, citing Brazil",
      "source": "Corteva Q3 2026 results release, 8-K",
      "as_of": "2026-11-11"
    },
    {
      "claim": "Year-to-date operating EPS through Q3 2026 was $0.76; adjusted pro forma operating EBITDA $943M, flat, margin 17.6%",
      "source": "Corteva Q3 2026 results release, 8-K",
      "as_of": "2026-11-11"
    },
    {
      "claim": "Q3 operating EPS of $0.06 missed the $0.10 consensus; revenue of $1.59B missed the $1.76B estimate",
      "source": "Proactive Investors, 2026-11-12",
      "as_of": "2026-11-12"
    },
    {
      "claim": "Crop protection new products grew 20% in Q3; biologicals sales fell 22% reported, 24% organic",
      "source": "Corteva Q3 2026 earnings presentation",
      "as_of": "2026-11-12"
    },
    {
      "claim": "Seed business distributed as Vylor Inc. (NYSE: VYLR), one share per Corteva share; Corteva kept the CTVA ticker",
      "source": "Vylor spin-off completion report, Pulse 2.0",
      "as_of": "2026-10-01"
    }
  ],
  "view_changes": [],
  "frame": null,
  "filed_numbers": {
    "as_of": "2026-11-13",
    "sector": "Consumer Defensive",
    "financials": {
      "status": "ok",
      "reason": null,
      "close_date": "2026-11-13",
      "latest_quarter": "2026-09-30",
      "figures": {
        "revenue": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-11-12",
              "value_musd": 2458,
              "yoy_pct": -6.1
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-31",
              "value_musd": 6379,
              "yoy_pct": -1.2
            },
            {
              "end": "2026-03-31",
              "filed": "2026-05-06",
              "value_musd": 4905,
              "yoy_pct": 11
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-12",
              "value_musd": 3910,
              "yoy_pct": -1.7
            },
            {
              "end": "2025-09-30",
              "filed": "2026-11-12",
              "value_musd": 2618,
              "yoy_pct": 12.6
            },
            {
              "end": "2025-06-30",
              "filed": "2026-07-31",
              "value_musd": 6456,
              "yoy_pct": 5.6
            }
          ]
        },
        "gross_margin": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-11-12",
              "pct": 37.6
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-31",
              "pct": 57.4
            },
            {
              "end": "2026-03-31",
              "filed": "2026-05-06",
              "pct": 51.6
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-12",
              "pct": 42.4
            },
            {
              "end": "2025-09-30",
              "filed": "2026-11-12",
              "pct": 37.2
            },
            {
              "end": "2025-06-30",
              "filed": "2026-07-31",
              "pct": 54.6
            }
          ]
        },
        "operating_margin": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-11-12",
              "pct": -22.6
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-31",
              "pct": 27.3
            },
            {
              "end": "2026-03-31",
              "filed": "2026-05-06",
              "pct": 19.9
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-12",
              "pct": 3.5
            },
            {
              "end": "2025-09-30",
              "filed": "2026-11-12",
              "pct": -13.3
            },
            {
              "end": "2025-06-30",
              "filed": "2026-07-31",
              "pct": 26.3
            }
          ]
        },
        "pretax_income": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": -589
        },
        "net_income": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "four_quarters_end": "2026-09-30",
          "value_musd": -570,
          "four_quarters_musd": 759
        },
        "operating_cash_flow": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "first_end": "2025-12-31",
          "value_musd": 427
        },
        "capital_spending": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "first_end": "2025-12-31",
          "value_musd": 576
        },
        "free_cash_flow": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "first_end": "2025-12-31",
          "value_musd": -149
        },
        "diluted_share_change": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "base_end": "2025-09-30",
          "pct": -1.6
        },
        "cash": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 3933
        },
        "debt": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 3458,
          "composition": "long-term debt"
        },
        "net_cash": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 475
        },
        "deferred_revenue": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 561,
          "yoy_pct": -7.4
        },
        "backlog": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 158,
          "yoy_pct": 7.5
        },
        "receivables": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 4797
        },
        "inventory": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 5482
        },
        "equity": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-11-12",
          "value_musd": 24493
        },
        "market_value": {
          "status": "ok",
          "close_date": "2026-11-13",
          "basis_end": "2026-11-05",
          "basis_filed": "2026-11-12",
          "value_musd": 6292.9
        },
        "enterprise_value": {
          "status": "ok",
          "close_date": "2026-11-13",
          "basis_end": "2026-11-05",
          "basis_filed": "2026-11-12",
          "value_musd": 5817.9
        },
        "ev_sales": {
          "status": "ok",
          "close_date": "2026-11-13",
          "basis_end": "2026-11-05",
          "basis_filed": "2026-11-12",
          "multiple": 0.3
        },
        "ev_ebit": {
          "status": "ok",
          "close_date": "2026-11-13",
          "basis_end": "2026-11-05",
          "basis_filed": "2026-11-12",
          "multiple": 2.5
        },
        "pe": {
          "status": "ok",
          "close_date": "2026-11-13",
          "basis_end": "2026-11-05",
          "basis_filed": "2026-11-12",
          "multiple": 8.3
        },
        "pb": {
          "status": "ok",
          "close_date": "2026-11-13",
          "basis_end": "2026-11-05",
          "basis_filed": "2026-11-12",
          "multiple": 0.3
        },
        "fcf_yield": {
          "status": "ok",
          "close_date": "2026-11-13",
          "basis_end": "2026-11-05",
          "basis_filed": "2026-11-12",
          "pct": -2.4
        }
      }
    },
    "short_interest": {
      "status": "ok",
      "settlement": "2026-10-15",
      "published": "2026-11-13",
      "short_pct_of_outstanding": 5.78,
      "days_to_cover": 1,
      "change_pct": 78.3
    },
    "insiders": {
      "status": "ok",
      "as_of": "2026-11-14",
      "windows": [
        {
          "days": 90,
          "status": "ok",
          "from": "2026-08-17",
          "bought_usd": 0,
          "sold_usd": 0,
          "bought_unpriced": 0,
          "sold_unpriced": 0
        },
        {
          "days": 365,
          "status": "ok",
          "from": "2025-11-15",
          "bought_usd": 0,
          "sold_usd": 636213.27,
          "bought_unpriced": 0,
          "sold_unpriced": 0
        }
      ]
    }
  },
  "body_markdown": "## Current Thesis\nCorteva is more likely to trail the S&P 500 over the next three months. On 2026-11-11 it reported its first quarter as a stand-alone crop-protection company, and it cut its 2026 profit outlook because Brazil \"was materially weaker than anticipated,\" in the words of Chief Executive Luke Kissam. The fourth-quarter report, expected in early February 2027, settles whether Latin America stabilises and what the first stand-alone outlook for 2027 looks like.\n\nThe rating is Low because the cut comes in the company's most important selling season. The causes the company names do not look like one-quarter problems: farmer cash shortages and costly credit in Brazil, distributors buying only as needed, and price competition on older products. Year-to-date adjusted operating earnings per share (EPS) through September were $0.76. The new full-year range is $0.76 to $0.80, so the bottom of the range is already reached and the fourth quarter adds little.\n\nThe market priced the cut in one session. The shares closed at $12.14 on 2026-11-11, before the report, and traded down 23% at $9.40 during the 2026-11-12 session, according to Proactive Investors. That price already assumes a smaller 2026 base. It does not yet reflect a reset 2027 outlook, which the company has not given.\n\n## Bull Case\n- **New products are still growing fast.** New crop-protection products grew 20% in the third quarter across all regions, led by Arylex and Pyraxalt, and new-product volume rose 14% year to date (Q3 2026 presentation, 2026-11-12).\n- **Outside Latin America, sales grew.** North American sales rose 7% to $574 million on 19% higher volume. Sales in Europe, the Middle East and Africa rose 12% to $239 million, and Asia Pacific rose 3% to $208 million (8-K results release, 2026-11-11).\n- **Nine-month margins held up.** Year-to-date adjusted pro forma operating EBITDA (earnings before interest, taxes, depreciation and amortisation) was $943 million, flat on the prior year, and the margin rose 30 basis points to 17.6% (8-K, 2026-11-11).\n- **The board authorised a dividend and a cost program.** The board authorised the first common dividend since the spin-off but did not state an amount. The company expects $130 million to $140 million of pre-tax restructuring charges in 2026, with the program substantially complete in 2028 (8-K, 2026-11-11).\n\n## Bear Case\n- **Latin America is in sharp decline.** Latin American sales fell 28% to $570 million in the third quarter. Organic sales fell 31%, on 24% lower volume and 7% lower prices (8-K, 2026-11-11).\n- **Pricing fell in two big regions.** Total third-quarter price fell 7% and volume 2%, for net sales of $1.591 billion, down 9%. The company cites U.S. acetochlor pricing and competition on molecules late in their life cycle in Latin America (8-K, 2026-11-11).\n- **The quarter missed by a wide margin.** Operating EPS of $0.06 fell 57% and missed the $0.10 consensus. Revenue of $1.59 billion missed the $1.76 billion estimate (Proactive Investors, 2026-11-12).\n- **The 2026 outlook fell well short of expectations.** Full-year adjusted pro forma operating EBITDA guidance is $1.100 billion to $1.125 billion, a 12% decline at the midpoint (Investing.com, 2026-11-12). The $0.76–$0.80 EPS range compares with a $1.07 consensus, according to news reports on 2026-11-11.\n- **Biologicals fell in the quarter.** Biologicals sales fell 22% in the third quarter, or 24% on an organic basis (Q3 2026 presentation, 2026-11-12).\n- **There is legal exposure on an older chemical.** A lawsuit over chlorpyrifos was filed against Corteva and The Dow Chemical Company, according to company news on 2026-11-09.\n\n## Setup & Price Structure\nCorteva distributed its seed business as Vylor Inc. (NYSE: VYLR) on 2026-10-01, one Vylor share for each Corteva share. Quoted prices before that date are for the combined company. The 52-week intraday high of $90.97 on 2026-07-29 is a pre-spin level and does not compare with today's shares.\n\nSince the spin-off, the shares have traded in a narrow range. The 52-week closing low is $11.33, set on 2026-10-28. The quoted close was $12.26 on 2026-11-04 and $12.14 on 2026-11-11, the last close before the results reaction. On adjusted daily closes, the 50-day moving average was $12.46 and the 200-day was $12.11 as of 2026-11-11, and the three-month change was 7.0%.\n\nThe 2026-11-12 session took the shares to about $9.40 intraday, according to Proactive Investors, well below the post-spin closing low of $11.33. If the session closes near that level, the stock sits about a quarter below both moving averages. For the shares to lead from here, they would have to recover the whole post-report drop while the company still has no 2027 outlook. No published analyst target is used here: every target found for the new Corteva dates from before the 2026-11-11 report.\n\n## Catalyst Calendar\n\n- **~2027-02-04 (est.):** Fourth-quarter 2026 report and first stand-alone 2027 outlook. Shows whether Latin American volume and pricing stop falling and sets the first full-year earnings base for the crop-protection company; a 2027 outlook above 2026 would challenge the lag call.\n\n## What Would Change Our Mind\n\nA daily close above $12.46, the 50-day average of adjusted closes as of 2026-11-11, which would show the shares recovering the whole post-report drop and leading. A fourth-quarter report showing Latin American organic sales growth would also prove the call wrong.\n\n## Correlation Notes\nSince 2026-10-01, Corteva trades as a pure crop-protection company. Its results now depend on how much farmers spend on chemicals and how easily they can get credit, especially in Brazil, more than on the seed-genetics cycle now carried by Vylor. The Brazilian season makes the fourth quarter and the first quarter the periods where the Latin American decline either repeats or eases.\n\nInsider filings give no signal on value. The SEC Form 4 filings dated 2026-11-03 are director stock grants of 2,792, 2,792 and 666 shares at $11.64 on 2026-10-30. They were awards, not open-market purchases. The 2026-09 Form 4s from the chief financial officer and the chief legal officer record shares withheld for tax at pre-spin prices.",
  "first_seen": "2026-11-12",
  "last_analyzed": "2026-11-12T18:06:45+00:00",
  "last_synthesized": "2026-11-12",
  "date_modified": "2026-11-12",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}